第三届CSCO妇科肿瘤专委会委员
上海市医学会第十二届子宫内膜异位症学组组员
上海市医学会妇科肿瘤分会卵巢癌学组委员
上海市研究型医院学会妇产科转化医学研究与发展专业委员会委员
上海市浦东新区医学会妇科专委会委员
全国老年学会妇科分会青年委员
上海市抗癌协会青年肿瘤临床科学家培育沙龙学员
上海市浦东新区女性健康管理导师团成员
中国优生科学协会肿瘤生殖学分会第二届委员会委员
上海市医师协会妇产科医师分会妇科内分泌工作组成员
上海市浦东新区-闵行区生育力保护联盟委员
Member of the Third Committee of the Gynecological Oncology Committee of CSCO
Member of the 12th Endometriosis Group of the Shanghai Medical Association
Member of the Ovarian Cancer Group of the Gynecological Oncology Branch of the Shanghai Medical Association
Member of the Professional Committee for Research and Development of Translational Medicine in Obstetrics and Gynecology of the Shanghai Research Hospital Association
Member of the Gynecology Committee of the Shanghai Pudong New Area Medical Association
Young Member of the Gynecology Branch of the National Geriatrics Society
Student of the Shanghai Anti-Cancer Association’s Young Clinical Scientist Training Salon for Oncology
Member of the Shanghai Pudong New Area Women’s Health Management Mentor Team
Member of the Second Committee of the Reproductive Oncology Branch of the Chinese Society of Eugenics and Reproductive Health
Member of the Gynecological Endocrinology Working Group of the Shanghai Physicians Association Gynecology and Obstetrics Branch
Member of the Shanghai Pudong New Area - Minhang District Fertility Preservation Alliance
科研奖励：
第十八届上海市医学科技奖 青年奖 主要完成人之一
上海市浦东职工科技创新成果入围奖 创新成果入围奖 第一完成人
上海市浦东职工科技创新成果入围奖 先进操作法入围奖 第一完成人
上海市抗癌协会青年肿瘤科学家沙龙学员
主持课题情况：
中央高校基本科研业务费专项资金资助 基于TSPO靶向的 Fe（III) -卟啉-顺铂（IV）纳米平台增强铁死亡克服卵巢癌耐药的机制研究和联合治疗策略观察 项目编号：22120240343研究年限：2024.4.1-2026.3.31
浦东新区面上项目基于适配体构建纳米探针并用于卵巢肿瘤标志物的检测研究 项目编号：PW2024A-14 研究年限：2025.12.31-2027.11.30
参与课题情况：
上海市课题 构建MnO2 NS 适配体高效检测宫颈HPV16/18L1的研究 课题编号：20204Y0141 研究年限2021.01.01-2023.12.31（已结题）
近五年发表代表性论文专著的情况：
Qiang S, Hu X, Li R, Wu W, Fang K, Li H, Sun Y, Liang S, Zhao W, Wang M, Lin Y, Shi S, Dong C. CuS Nanoparticles-Loaded and Cisplatin Prodrug Conjugated Fe(III)-MOFs for MRI-Guided Combination of Chemotherapy and NIR-II Photothermal Therapy. ACS Appl Mater Interfaces. 2022 Aug 17;14(32):36503-36514.（IF=10.383）
Qiang S, Fu F, Wang J, Dong C. Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making. Front Genet. 2022 Oct 13;13:1007108.（IF=3.789）
Hu X, Li H, Li R, Qiang S, Chen M, Shi S, Dong C. A Phase-Change Mediated Intelligent Nanoplatform for Chemo/Photothermal/Photodynamic Therapy of Cancer. Adv Healthc Mater. 2023 Feb;12(5):e2202245.（IF=10）
Zhao W, Hu X, Li W, Li R, Chen J, Zhou L, Qiang S, Wu W, Shi S, Dong C. M2-Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy. Small. 2021 Apr;17(13):e2007051. （IF=13）
Yu Wang a,1, Zhongqi Cuia , Yang WangChunhui Wanga, Yue Zhang, Nan Huang aXinda Yang, Fenyong Suna, Sufeng Oiang , Shuo Shia, Bing Shen a.ISRIB-loaded nanoplatform disrupts cellular homeostasis by depletingglutathione and inhibiting stress granules formation to driveimmunosuppressive reprogramming. Chemical Engineering Journal 523(2025)168568. (IF=15.1)
Awards received in the past three years
18th Shanghai Medical Science and Technology Award Youth Award The 10th recipient
Shanghai Pudong Employee Science and Technology Innovation Achievement Nomination Award Innovation Achievement Nomination Award First Completed Person
Trainee of the Shanghai Anti Cancer Association Young Oncologist Salon
Leading research projects in the past three years
Fundamental Research Funds for the Central Universities Mechanism study and combination therapy strategy observation of Fe (III) - porphyrin cisplatin (IV) nanoplatform based on TSPO targeting to enhance ferroptosis and overcome drug resistance in ovarian cancer Project Number 22120240343 Research Duration: April 1, 2024 to March 31, 2026
Pudong New Area General Project Research on the Construction of Nanoprobe Based on Aptamer and Its Application in the Detection of Ovarian Tumor Markers Project Number: PW2024A-14 Research Duration: December 31, 2025 - November 30, 2027
Participation in research projects in the past five years
Shanghai research project Study on the construction of MnO2 NS adapter for efficient detection of cervical HPV16/18L1 project number 20204Y0141 Research Duration: January 1, 2021 to December 31, 2023 (completed)
Representative papers and monographs published in the past five years
Qiang S, Hu X, Li R, Wu W, Fang K, Li H, Sun Y, Liang S, Zhao W, Wang M, Lin Y, Shi S, Dong C. CuS Nanoparticles-Loaded and Cisplatin Prodrug Conjugated Fe(III)-MOFs for MRI-Guided Combination of Chemotherapy and NIR-II Photothermal Therapy. ACS Appl Mater Interfaces. 2022 Aug 17;14(32):36503-36514.（IF=10.383）
Qiang S, Fu F, Wang J, Dong C. Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making. Front Genet. 2022 Oct 13;13:1007108.（IF=3.789）
Hu X, Li H, Li R, Qiang S, Chen M, Shi S, Dong C. A Phase-Change Mediated Intelligent Nanoplatform for Chemo/Photothermal/Photodynamic Therapy of Cancer. Adv Healthc Mater. 2023 Feb;12(5):e2202245.（IF=10）
Zhao W, Hu X, Li W, Li R, Chen J, Zhou L, Qiang S, Wu W, Shi S, Dong C. M2-Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy. Small. 2021 Apr;17(13):e2007051. (IF=13)
Yu Wang a,1, Zhongqi Cuia , Yang WangChunhui Wanga, Yue Zhang, Nan Huang aXinda Yang, Fenyong Suna, Sufeng Oiang , Shuo Shia, Bing Shen a.ISRIB-loaded nanoplatform disrupts cellular homeostasis by depletingglutathione and inhibiting stress granules formation to driveimmunosuppressive reprogramming. Chemical Engineering Journal 523(2025)168568. (IF=15.1)
